Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-740299.00.
ENTERPRISE VALUE (EV)
$-740299.00
CollPlant Biotechnologies Ltd.
Market Cap
$4.40M
Enterprise Value (EV)
$-740299.00
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| CollPlant Biotechnologies Ltd. (CLGN) | $4.40M | $-740299.00 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.49M | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.29M | $315452.00 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | $92036.00 |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.63M | $1.24M |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | $1.01M |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.98M | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.81M | $8.22M |
| CalciMedica, Inc. (CALC)vs › | $4.85M | N/A |
Market Cap
$4.40M
Total Debt
$814000.00
Cash
$5.95M
Enterprise Value
$-740299.00
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
